{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:5756",
      "entity_text" : "oestriol",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "interpro:IPR007122",
      "entity_text" : "gel",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In fact, a new ultralow-dose oestriol vaginal gel formulation (0.005% oestriol vaginal gel), which significantly enhances oestriol delivery to vaginal tissue, compared with existing formulations, has been developed, thus allowing the use of much lower doses of oestriol to treat vaginal atrophy [XREF_BIBR].",
  "reading_complete" : "2020-08-02T18:18:19Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T18:10:28Z",
  "trigger" : "enhances",
  "evidence" : [ "gel formulation (0.005% oestriol vaginal gel), which significantly enhances oestriol" ],
  "pmc_id" : "6719636",
  "score" : 0
}